reference/22989497

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22989497

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	2585
issn	0008-5472 1538-7445
issueIdentifier	12
pageRange	2575-2585
publicationName	Cancer Research
startingPage	2575
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_08904c18bb654f13883d9be4ae1b268f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_47760e40b98220f3ddb8ceb17d03af3c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c5027b329d91933e681e5e636c54a0f4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f14bf2ae819405d8ff0aa157049b9a1e
bibliographicCitation	Tähtinen S, Feola S, Capasso C, Laustio N, Groeneveldt C, Ylösmäki EO, Ylösmäki L, Martins B, Fusciello M, Medeot M, Tagliamonte M, Chiaro J, Hamdan F, Peltonen K, Ranki T, Buonaguro L, Cerullo V. Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy. Cancer Res. 2020 Jun 15;80(12):2575–85. doi: 10.1158/0008-5472.can-19-2062. PMID: 32107211.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7166-3018 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1742-1517 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7167-4817 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d7aa23c33a389745885b9f26cab3261 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4b5d3ac0943c69992a32a7a97676500 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9678-2614 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5bdf19ca5fc1306b6110dd2f23087235 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c23f50b5f8032a82e7b09f171f7c6ee http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4678-7382 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3f8bad339b5b5bf99d60451b2dc3dd9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea6f9532dd949973c86532548f00b8d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a41293501a9a802850a0a6031971803b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3063-451X http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4901-3796 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6380-7114 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36e13f033eb8217719e45b392be9dcf6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4012-4310 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f84ac550c88714b92678f3ef9488d72d
date	2020-06-15^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/32107211 https://doi.org/10.1158/0008-5472.can-19-2062
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2786 https://portal.issn.org/resource/ISSN/1538-7445 https://portal.issn.org/resource/ISSN/0008-5472
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy
discusses	http://id.nlm.nih.gov/mesh/M0024109 http://id.nlm.nih.gov/mesh/M0556121 http://id.nlm.nih.gov/mesh/M0026869 http://id.nlm.nih.gov/mesh/M0028986 http://id.nlm.nih.gov/mesh/M000626416 http://id.nlm.nih.gov/mesh/M0017115 http://id.nlm.nih.gov/mesh/M0429936 http://id.nlm.nih.gov/mesh/M0145407 http://id.nlm.nih.gov/mesh/M0001435 http://id.nlm.nih.gov/mesh/M0001420 http://id.nlm.nih.gov/mesh/M0023721
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008546Q000628 http://id.nlm.nih.gov/mesh/D007167Q000379 http://id.nlm.nih.gov/mesh/D007156 http://id.nlm.nih.gov/mesh/D019496Q000008 http://id.nlm.nih.gov/mesh/D011054Q000008 http://id.nlm.nih.gov/mesh/D015721Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D061026Q000037 http://id.nlm.nih.gov/mesh/D000951Q000235 http://id.nlm.nih.gov/mesh/D000256Q000276 http://id.nlm.nih.gov/mesh/D045744Q000637 http://id.nlm.nih.gov/mesh/D015395Q000276 http://id.nlm.nih.gov/mesh/D019496Q000276 http://id.nlm.nih.gov/mesh/D017778Q000008 http://id.nlm.nih.gov/mesh/D050504Q000276 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D050504Q000235 http://id.nlm.nih.gov/mesh/D000951Q000276 http://id.nlm.nih.gov/mesh/D008546Q000276 http://id.nlm.nih.gov/mesh/D015496Q000276 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D017778Q000276 http://id.nlm.nih.gov/mesh/D015721Q000276 http://id.nlm.nih.gov/mesh/D061026Q000276 http://id.nlm.nih.gov/mesh/D000256Q000235 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000074322Q000008 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D013602Q000276 http://id.nlm.nih.gov/mesh/D015395Q000235 http://id.nlm.nih.gov/mesh/D000949Q000235 http://id.nlm.nih.gov/mesh/D008546Q000473 http://id.nlm.nih.gov/mesh/D000949Q000276 http://id.nlm.nih.gov/mesh/D011054Q000276
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b83d04d3e3b05ce10d1a5893dc850a9b http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_46a6fcbc95e576e1ddb6979b4e08f686 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9391 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e

Showing number of triples: 1 to 91 of 91.